source
- Dr Sznol on Biomarkers of Response in Metastatic MelanomaMario Sznol, MD, discusses the uncertainties around predicting benefit with immune checkpoint inhibitors in metastatic melanoma.onclive · 2mo ago↗ source
- Transformational Utah Investment in Artificial Intelligence and Computing to Advance Health and DiscoveryThe State of Utah has made a visionary investment in AI and advanced computing infrastructure to advance research.onclive · 2mo ago↗ source
- Madrigal's Rezdiffra beats estimates; Gilead cuts jobs; Banyan debuts🚀 Madrigal Pharmaceuticals' MASH drug beats expectations: The biotech’s Rezdiffra sales came in at $311 million for the first quarter, surpassing analysts’ projections by about $10 million, accord…Endpoints